$9.32
Inogen is a medical devices business based in the US. Inogen shares (INGN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $9.19 – a decrease of 2.03% over the previous week. Inogen employs 834 staff and has a trailing 12-month revenue of around $326.7 million.
Our top picks for where to buy Inogen stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Inogen stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – INGN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Inogen stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Inogen stock price (NASDAQ: INGN)
Use our graph to track the performance of INGN stocks over time.Inogen shares at a glance
Latest market close | $9.19 |
---|---|
52-week range | $4.13 - $13.33 |
50-day moving average | $10.95 |
200-day moving average | $8.47 |
Wall St. target price | $10.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-4.05 |
Is it a good time to buy Inogen stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Inogen price performance over time
Historical closes compared with the close of $9.47 from 2024-10-18
1 week (2024-10-16) | 0.96% |
---|---|
1 month (2024-09-23) | -7.61% |
3 months (2024-07-23) | -1.66% |
6 months (2024-04-23) | 37.25% |
1 year (2023-10-23) | 113.77% |
---|---|
2 years (2022-10-21) | -52.82% |
3 years (2021-10-22) | 41.28 |
5 years (2019-10-23) | 52.01 |
Is Inogen stock undervalued or overvalued?
Valuing Inogen stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inogen's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Inogen's PEG ratio
Inogen's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.48. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Inogen's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Inogen financials
Revenue TTM | $326.7 million |
---|---|
Gross profit TTM | $153.5 million |
Return on assets TTM | -10% |
Return on equity TTM | -39.99% |
Profit margin | -28.3% |
Book value | $7.91 |
Market Capitalization | $217.7 million |
TTM: trailing 12 months
Inogen share dividends
We're not expecting Inogen to pay a dividend over the next 12 months.
Inogen share price volatility
Over the last 12 months, Inogen's shares have ranged in value from as little as $4.13 up to $13.3299. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inogen's is 1.042. This would suggest that Inogen's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Inogen overview
Inogen, Inc. , a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Frequently asked questions
nullWhat percentage of Inogen is owned by insiders or institutions?
Currently 1.788% of Inogen shares are held by insiders and 95.909% by institutions. How many people work for Inogen?
Latest data suggests 834 work at Inogen. When does the fiscal year end for Inogen?
Inogen's fiscal year ends in December. Where is Inogen based?
Inogen's address is: 859 Ward Drive, Goleta, CA, United States, 93111 What is Inogen's ISIN number?
Inogen's international securities identification number is: US45780L1044 What is Inogen's CUSIP number?
Inogen's Committee on Uniform Securities Identification Procedures number is: 45780L104
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question